Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Charcot's Joint

fluorodeoxyglucose f18 has been researched along with Charcot's Joint in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huijberts, MS; Pickwell, KM; Schaper, NC; van Hirtum, PV; van Kroonenburgh, MJ; Weijers, RE1
Alavi, A; Basu, S; Chryssikos, T; Houseni, M; Scot Malay, D; Shah, J; Zhuang, H1
Alavi, A; Alnafisi, N; Yun, M1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Charcot's Joint

ArticleYear
Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?
    Nuclear medicine communications, 2007, Volume: 28, Issue:6

    Topics: Adult; Aged; Arthropathy, Neurogenic; Diabetic Foot; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteomyelitis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Infections

2007

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Charcot's Joint

ArticleYear
F-18 FDG PET/CT scanning in Charcot disease: a brief report.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:1

    Topics: Adult; Aged; Arthropathy, Neurogenic; Female; Fluorodeoxyglucose F18; Foot; Humans; Male; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2011
F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:7

    Topics: Arthritis, Infectious; Arthropathy, Neurogenic; Diabetes Mellitus, Type 1; Diabetic Foot; Diabetic Neuropathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Metatarsal Bones; Middle Aged; Osteomyelitis; Radiopharmaceuticals; Tomography, Emission-Computed

2001